Cost-Effectiveness of Introducing a Rotavirus Vaccine in Developing Countries: The Case of Mexico
This study, published in BMC Infectious Diseases, developed a model to compare the cost and disease burden of rotavirus in unvaccinated children in Mexico. The study determined that it would be highly cost-effective to include rotavirus vaccine in the national immunization program, especially among poorer populations and those with less access to medical care.
Author(s): Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R
Published: 2008
Visit web page (English)
(Located at www.pubmedcentral.nih.gov)
Citation: Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R. Cost-effectiveness of Introducing a Rotavirus Vaccine in Developing Countries: The Case of Mexico. BMC Infectious Diseases. 2008;8:103-116.
Resource types: Peer-reviewed journal
Diseases: Rotavirus
Topics: Immunization financing; Disease burden and surveillance; Disease/vaccine specific information
Regions: Latin America

